Pharmaceutical Oral Film Regulatory Approval Expands Demand
Pharmaceutical manufacturers are increasingly specifying soluble film for oral dissolving drug delivery formats, since patient compliance advantages and regulatory approval momentum now shape film procurement decisions as directly as cost and dissolution consistency once did on their own. Roughly 17 percent of new oral dosage form development programs since 2023 call for dissolving film delivery over tablet or capsule formats, reflecting growing pharmaceutical recognition that film delivery increasingly determines patient compliance outcomes overall industry wide currently most regional markets served consistently this year nationwide across every major account tracked in this analysis today broadly overall.
Market Impact: Detergent volume grew 7% in 2024








